Endothelial Growth Factors
-
Subject Areas on Research
-
Adaptive mechanisms that preserve cardiac function in mice without myoglobin.
-
Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis.
-
Aged human muscle demonstrates an altered gene expression profile consistent with an impaired response to exercise.
-
Ameroid constrictor versus hydraulic occluder: creation of hibernating myocardium.
-
Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury.
-
Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia.
-
Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.
-
Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
-
Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury.
-
Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization.
-
Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.
-
Cutaneous lesions of secondary syphilis are highly angiogenic.
-
Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.
-
Differential expression of VEGF isoforms in mouse during development and in the adult.
-
Direct myocardial revascularization and angiogenesis--how many patients might be eligible?
-
Early wound healing exhibits cytokine surge without evidence of hypoxia.
-
Effect of host microenvironment on the microcirculation of human colon adenocarcinoma.
-
Effect of ionizing radiation on thymidine uptake, differentiation, and VEGFR2 receptor expression in endothelial cells: the role of VEGF(165).
-
Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts.
-
Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.
-
Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor.
-
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
-
Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
-
Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics.
-
Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.
-
Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
-
HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity.
-
Healing of a free tracheal autograft is enhanced by topical vascular endothelial growth factor in an experimental rabbit model.
-
Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity.
-
Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle.
-
Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.
-
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer.
-
Long- and short-term effects of biological hydrogels on capsule microvascular density around implants in rats.
-
Molecular profile and partial functional analysis of novel endothelial cell-derived growth factors that regulate hematopoiesis.
-
PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects.
-
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
-
Phase I study of recombinant human endostatin in patients with advanced solid tumors.
-
Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity.
-
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.
-
Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage.
-
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
-
Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment.
-
Radiation-induced hypoxia may perpetuate late normal tissue injury.
-
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
-
Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin.
-
Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells.
-
Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation.
-
Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.
-
Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.
-
Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
-
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
-
Synergy between tumor immunotherapy and antiangiogenic therapy.
-
Technology evaluation: VEGF165 gene therapy, Valentis Inc.
-
The conformation-dependent interaction of alpha 2-macroglobulin with vascular endothelial growth factor. A novel mechanism of alpha 2-macroglobulin/growth factor binding.
-
The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype.
-
The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression.
-
The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer.
-
Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.
-
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
-
Topical VEGF enhances healing of thoracic aortic anastomosis for coarctation in a rabbit model.
-
Treatment of Metastatic Colorectal Cancer: ASCO Guideline.
-
Use of SMART-generated cDNA for gene expression studies in multiple human tumors.
-
VEGF increases retinal vascular ICAM-1 expression in vivo.
-
VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases.
-
VITRECTOMY FOR DIABETIC COMPLICATIONS: A Pooled Analysis of Randomized Controlled Trials Using Modern Techniques and Equipment.
-
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study.
-
Vascular endothelial growth factor expression in pig latissimus dorsi myocutaneous flaps after ischemia reperfusion injury.
-
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
-
Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades.
-
Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells.
-
[A novel model for visualization of tumor cell-induced angiogenesis in vivo].
-
[Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
-
p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.